Advertisement
Screener

ICOSAVAX, INC. Share-based Payment Arrangement, Expense

ICOSAVAX, INC. Share-based Payment Arrangement, Expense

ICOSAVAX, INC. reported Share-based Payment Arrangement, Expense of $6.60 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2023-11-14

  • ICOSAVAX, INC. share-based payment arrangement, expense for the quarter ending 2023-09-30 was $6.60M, a 21.49% increase year-over-year.
  • ICOSAVAX, INC. share-based payment arrangement, expense for the quarter ending 2023-06-30 was $6.31M, a 13.67% increase year-over-year.
  • ICOSAVAX, INC. share-based payment arrangement, expense for the quarter ending 2023-03-31 was $6.00M, a 31.87% increase year-over-year.
  • ICOSAVAX, INC. share-based payment arrangement, expense for the quarter ending 2022-12-31 was $6.16M, a 67.47% increase year-over-year.
  • ICOSAVAX, INC. share-based payment arrangement, expense for fiscal 2022 was $21.69M, a 25.27% decline from fiscal 2021.
  • ICOSAVAX, INC. share-based payment arrangement, expense for fiscal 2021 was $29.03M, a 11196.11% increase from fiscal 2020.
  • ICOSAVAX, INC. share-based payment arrangement, expense for fiscal 2020 was $257.00K.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2023-09-30$6.60M
10-Q · filed 2023-11-14
$12.91M
derived: sum of 2 quarters · filed 2023-11-14
$18.91M
10-Q · filed 2023-11-14
$25.07M
derived: sum of 4 quarters · filed 2023-11-14
2023-06-30$6.31M
10-Q · filed 2023-08-14
$12.31M
10-Q · filed 2023-08-14
$18.47M
derived: sum of 3 quarters · filed 2023-08-14
$23.90M
derived: sum of 4 quarters · filed 2023-11-14
2023-03-31$6.00M
10-Q · filed 2023-05-10
$12.16M
derived: sum of 2 quarters · filed 2023-05-10
$17.59M
derived: sum of 3 quarters · filed 2023-11-14
$23.14M
derived: sum of 4 quarters · filed 2023-11-14
2022-12-31$6.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$11.59M
derived: sum of 2 quarters · filed 2023-11-14
$17.14M
derived: sum of 3 quarters · filed 2023-11-14
$21.69M
10-K · filed 2023-03-30
2022-09-30$5.43M
10-Q · filed 2023-11-14
$10.99M
derived: sum of 2 quarters · filed 2023-11-14
$15.54M
10-Q · filed 2023-11-14
$19.21M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$5.55M
10-Q · filed 2023-08-14
$10.10M
10-Q · filed 2023-08-14
$13.78M
derived: sum of 3 quarters · filed 2023-08-14
$37.45M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$4.55M
10-Q · filed 2023-05-10
$8.23M
derived: sum of 2 quarters · filed 2023-05-10
$31.90M
derived: sum of 3 quarters · filed 2023-05-10
$33.30M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$3.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$27.35M
derived: sum of 2 quarters · filed 2023-03-30
$28.75M
derived: sum of 3 quarters · filed 2023-03-30
$29.03M
10-K · filed 2023-03-30
2021-09-30$23.67M
10-Q · filed 2022-11-14
$25.08M
derived: sum of 2 quarters · filed 2022-11-14
$25.35M
10-Q · filed 2022-11-14
$25.42M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$1.41M
10-Q · filed 2022-08-15
$1.68M
10-Q · filed 2022-08-15
$1.75M
derived: sum of 3 quarters · filed 2022-08-15
$1.82M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$276.00K
10-Q · filed 2022-05-16
$346.00K
derived: sum of 2 quarters · filed 2022-05-16
$416.00K
derived: sum of 3 quarters · filed 2022-05-16
$479.00K
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$70.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
$140.00K
derived: sum of 2 quarters · filed 2022-03-30
$203.00K
derived: sum of 3 quarters · filed 2022-03-30
$257.00K
10-K · filed 2022-03-30
2020-09-30$70.00K
10-Q · filed 2021-11-15
$133.00K
derived: sum of 2 quarters · filed 2021-11-15
$187.00K
10-Q · filed 2021-11-15
2020-06-30$63.00K
10-Q · filed 2021-09-13
$117.00K
10-Q · filed 2021-09-13